Literature DB >> 27890580

Lipid-free apoA-I structure - Origins of model diversity.

Michael N Oda1.   

Abstract

Apolipoprotein A-I (apoA-I) is a prominent member of the exchangeable apolipoprotein class of proteins, capable of transitioning between lipid-bound and lipid-free states. It is the primary structural and functional protein of high density lipoprotein (HDL). Lipid-free apoA-I is critical to de novo HDL formation as it is the preferred substrate of the lipid transporter, ATP Binding Cassette Transporter A1 (ABCA1) Remaley et al. (2001) [1]. Lipid-free apoA-I is an important element in reverse cholesterol transport and comprehension of its structure is a core issue in our understanding of cholesterol metabolism. However, lipid-free apoA-I is highly conformationally dynamic making it a challenging subject for structural analysis. Over the past 20years there have been significant advances in overcoming the dynamic nature of lipid-free apoA-I, which have resulted in a multitude of proposed conformational models.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apolipoprotein A-I; High density lipoprotein cholesterol; Protein structure

Mesh:

Substances:

Year:  2016        PMID: 27890580     DOI: 10.1016/j.bbalip.2016.11.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  5 in total

1.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

2.  Proteomic Toolbox To Standardize the Separation of Extracellular Vesicles and Lipoprotein Particles.

Authors:  Tingting Wang; Illarion V Turko
Journal:  J Proteome Res       Date:  2018-08-16       Impact factor: 4.466

3.  Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal Antibodies.

Authors:  Hitoshi Kimura; Shiho Mikawa; Chiharu Mizuguchi; Yuki Horie; Izumi Morita; Hiroyuki Oyama; Takashi Ohgita; Kazuchika Nishitsuji; Atsuko Takeuchi; Sissel Lund-Katz; Kenichi Akaji; Norihiro Kobayashi; Hiroyuki Saito
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

Review 4.  Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology.

Authors:  Paola Rampelotto Ziani; Jacson Gabriel Feiten; Jéferson Ferraz Goularte; Rafael Colombo; Bárbara Antqueviezc; Luiza Paul Géa; Adriane Ribeiro Rosa
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

5.  A short peptide of the C-terminal class Y helices of apolipoprotein A-I has preserved functions in cholesterol efflux and in vivo metabolic control.

Authors:  Shelley J Edmunds; Rebeca Liébana-García; Karin G Stenkula; Jens O Lagerstedt
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.